The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Moves on Peptides: What Compounding Pharmacies Need to Know The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University